Comparison of intracranial (IC) response assessment criteria in patients (pts) with melanoma brain metastases (MBM) treated with combination nivolumab (NIVO) plus ipilimumab (IPI) in CheckMate 204 Meeting Abstract


Authors: Huang, R.; Youssef, G.; Nelson, T.; Wen, P.; Forsyth, P.; Hodi, F. S.; Margolin, K. A.; Algazi, A. P.; Hamid, O.; Lao, C. D.; Ernstoff, M. S.; Moschos, S. J.; Atkins, M. B.; Postow, M.; Reardon, D. A.; Grootendorst, D. J.; Askelson, M.; Ritchings, C.; Tawbi, H. A.
Abstract Title: Comparison of intracranial (IC) response assessment criteria in patients (pts) with melanoma brain metastases (MBM) treated with combination nivolumab (NIVO) plus ipilimumab (IPI) in CheckMate 204
Meeting Title: ESMO Congress 2023
Journal Title: Annals of Oncology
Volume: 34
Issue: Suppl. 2
Meeting Dates: 2023 Oct 20-24
Meeting Location: Madrid, Spain
ISSN: 0923-7534
Publisher: Oxford University Press  
Date Published: 2023-10-01
Start Page: S680
End Page: S681
Language: English
ACCESSION: WOS:001087480201466
DOI: 10.1016/j.annonc.2023.09.2269
PROVIDER: wos
Notes: Meeting Abstract: 1135P -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Michael Andrew Postow
    361 Postow